Ambu tops STOXX on outlook hike, strong Q1 prelims

Ambu A/S

10/01/2025 08:26

** Shares in Danish medical devices maker Ambu  AMBUb.CO 
jump 13% to the top of the pan-European STOXX 600  .STOXX  after
it posted preliminary Q1 results and hiked it full-year outlook 
    ** It now targets 2024/25 organic revenue growth of 11-14%
vs previous outlook of 10-13%
    ** It sees 2024/25 EBIT margin before special items at
13-15% vs 12-14% previously
    ** It reports preliminary Q1 revenue of DKK 1.51 bln ($208.4
mln) and EBIT before special items of DKK 243 mln
    ** "The high-end of Ambu's new guidance implies consensus
estimates going up ~10%, below today's share price reaction and
also comes on top of positive momentum in the stock in recent
days," ABG Sundal Collier analyst Morten Larsen says
    ** "But strong Q1 alleviates a lot of fears e.g. making the
new guidance range looking cautious, and alleviate fears over
recent weakening growth in the Pulmonology endoscope business
and how much Ambu may need to boost OPEX spending," he adds
    ** If the gains hold, the shares are on track for their best
day since 2021

($1 = 7.2468 Danish crowns)

 (Reporting by Elviira Luoma)
 ((Elviira.luoma@thomsonreuters.com))